Use of interferon subtype alpha-8 (IFN-.alpha..sub.8) to treat viral infections of the liver
US6007805A · kind A · utility
37Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1996 |
| Grant date | Dec 28, 1999 |
| Priority date | — |
| Expiry date | Sep 24, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Individual subtypes of interferon-.alpha. (IFN-.alpha.) have been found to have different antiviral activity in different cell types and are therefore used to prevent or treat viral infections in cell types in which they are most active. The individual subtype of choice has relatively low antiviral activity in other celltypes to reduce the risk of side effects. IFN-.alpha..sub.10 and/or IFN-.alpha..sub.17 are preferred for use in treating viral lung infections and IFN-.alpha..sub.8 is preferred for use in treating viral liver infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.